Hansaitai Biopharmaceutical Technology (Wuhan) Co Ltd Sustainability Reports
The company is an innovative biotechnology enterprise focused on structural biology, translational medicine, and clinical development. It discovers, develops, and commercializes precision immunotherapeutic products for the treatment of cancer and autoimmune diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01Z1LMCT1
2 reports from 2025 to 2025
